Sign in

CIK 0000014272

  • Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
220790350
Phone
+1 609-252-4621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-31 YALE PHYLLIS R Director Grant or award · Deferred Share Units +462.14 $73.03 $34K 14,855.16
2022-03-31 Haller Julia A Director Grant or award · Deferred Share Units +462.14 $73.03 $34K 15,107.7
2022-03-31 Arduini Peter J Director Grant or award · Deferred Share Units +462.14 $73.03 $34K 38,266.11
2022-03-31 Rice Derica W Director Grant or award · Deferred Share Units +496.37 $73.03 $36K 10,858.92
2022-03-22 Caforio Giovanni Board Chair and CEO Gift −420 581,104.33
2022-03-21 Caforio Giovanni Board Chair and CEO Sale −25,000 $71.52 $1.8M 581,524.33
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Sale −31,331 $69.27 $2.2M 46,308
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Option exercise +21,288 $66.35 $1.4M 67,596
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Option exercise +5,294 $55.52 $294K 72,890
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Option exercise +12,233 $54.29 $664K 85,123
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Option exercise +8,490 $38.41 $326K 93,613
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Sale −43,228 $69.23 $3.0M 50,385
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Option exercise · Option (right to buy) −21,288 0
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Option exercise · Option (right to buy) −12,233 0
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Option exercise · Option (right to buy) −5,294 0
2022-03-16 VESSEY RUPERT EVP, Research & Early Dev. Option exercise · Option (right to buy) −8,490 8,491
2022-03-14 Santiago Karen Murphy SVP & Controller Sale −6,577 $69.20 $455K 16,704
2022-03-14 BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer Sale −29,532 $69.20 $2.0M 41,966
2022-03-10 Shanahan Karin EVP, Glob. Prod. Dev. & Supply Grant or award · Market Share Units +9,789 9,789
2022-03-10 Shanahan Karin EVP, Glob. Prod. Dev. & Supply Grant or award · Performance Shares +14,683 14,683

Page 57 of 73 · 1,445 trades